The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study.
 
Yuqin Song
No Relationships to Disclose
 
Quanli Gao
No Relationships to Disclose
 
Huilai Zhang
No Relationships to Disclose
 
Lei Fan
No Relationships to Disclose
 
Jianfeng Zhou
No Relationships to Disclose
 
Dehui Zou
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Haiyan Yang
No Relationships to Disclose
 
Ting Liu
No Relationships to Disclose
 
Quanshun Wang
No Relationships to Disclose
 
Fangfang Lv
No Relationships to Disclose
 
Haiyi Guo
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Liudi Yang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
William F. Novotny
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Yidi Wang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jun Zhu
No Relationships to Disclose